Du är här

2014-04-09

DSM N.V. : DSM in exclusive discussions to acquire Aland (China)

Royal DSM,
the global Life Sciences and Materials Sciences company,
announces today it is in exclusive discussions with Aland Nutraceutical
Holding, Ltd. ("Aland") that may or may not result in the acquisition of
Aland, a China-based global producer of vitamin C. Further information will
be announced in due course, if and when appropriate.

If successful, this relatively small acquisition would allow DSM to further
strengthen its position in vitamin C. For DSM the acquisition, which would
fully meet its financial and strategic requirements, would add to its
position in vitamin C, the world's largest vitamin measured by volume. Aland
would also improve DSM's global footprint in vitamins for Human
Nutrition&Health, Animal Nutrition&Health and Personal Care, as it adds to
DSM's existing vitamin C capacity in Dalry (Scotland, United Kingdom) to
which the company remains fully committed.

Aland was founded in 1990 and has a production facility in the Jiangsu
Province in China. In 2013 the company realized net sales of about USD 90
million in vitamin C.

Vitamin C is an essential health ingredient that the body cannot produce
itself and that needs to be absorbed through diet or supplementation. Vitamin
C is widely found in fruits and vegetables. The recommended dietary
allowances for vitamin C in the United States were recently revised upwards
to 90 mg/day for men and 75 mg/day for women.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and
Materials Sciences DSM is driving economic prosperity, environmental progress
and social advances to create sustainable value for all stakeholders
simultaneously. DSM delivers innovative solutions that nourish, protect and
improve performance in global markets such as food and dietary supplements,
personal care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials.
DSM's 24,500 employees deliver annual net sales of around €10 billion. The
company is listed on NYSE Euronext. More information can be found
atwww.dsm.com.

Or find us on:

For more information:

-----------------------------------------------------------------------------------
|DSM Corporate CommunicationsHerman Betten DSM Investor RelationsDave Huizing |
|tel. +31 (0) 45 5782017 |
|e-mailmedia.contacts@dsm.com tel. +31 (0) 45 5782864 |
| e-mailinvestor.relations@dsm.com |
-----------------------------------------------------------------------------------
Press release-pdf
http://hugin.info/130663/R/1775460/605679.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire

HUG#1775460

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.